3 Consumer Housewares Maker, Auto Components Maker and Specialty Drugs Maker Stocks With a Strong Future Roadmap: Cello World, UNO Minda and Natco Pharma

Housewares, auto parts and pharma stocks let investors follow companies that serve a growing part of the Indian economy. Cello World, UNO Minda and Natco Pharma cover a consumer housewares maker, an auto components maker and a specialty drugs maker.

This list covers three housewares, auto parts and pharma stocks with complete current figures: Cello World, UNO Minda and Natco Pharma. Every figure comes from the latest reported financials and the 12 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Housewares, Auto Parts and Pharma Stocks?

Housewares, auto parts and pharma stocks are listed companies that make plastic and steel housewares, writing instruments and cleaning tools, make switches, lighting and sensors for vehicles, and make medicines for cancer and other complex conditions. Their earnings depend on household demand, vehicle output and drug demand.

Housewares, Auto Parts and Pharma Stocks at a Glance

On valuation, Cello World and Natco Pharma trade at a P/E below the industry P/E, while UNO Minda trades above it, which reflects the growth the market already expects. Readers comparing housewares, auto parts and pharma stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Housewares, Auto Parts and Pharma Stocks Have a Strong Roadmap in India?

Housewares, auto parts and pharma stocks have a strong roadmap in India because rising household spending, growing vehicle output and wider access to specialty treatments keep widening the market for these companies.

• Housewares. Households buy branded kitchen products.
• Auto components. Vehicles carry more electronics.
• Specialty drugs. Patients need advanced treatments.

Why Cello World Features Among These Housewares, Auto Parts and Pharma Stocks

Among the housewares, auto parts and pharma stocks on this list, Cello World is a consumer products company that sells houseware, writing instruments, glassware and moulded furniture under the Cello brand through a wide distribution network.

Revenue rose from Rs 1,375 crore in FY22 to Rs 2,379 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 220 crore in FY22 to Rs 332 crore in FY26, which works out to a compound annual growth rate of 10.9%.

The company has a return on equity of 12.3%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 7,985 crore. The stock trades at a P/E of 24.6, below the industry P/E of 41.4.

Roadmap: The company is growing its glassware and houseware ranges and expanding its reach in modern retail. A trusted household brand helps it enter new product categories.

What to watch: Track growth in glassware and writing instruments, distribution expansion and input costs.

Why UNO Minda Features Among These Housewares, Auto Parts and Pharma Stocks

Among the kitchen products, lighting and cancer drug shares on this list, UNO Minda is a Gurugram-based global automotive supplier of switches, lighting, sensors, alloy wheels, controllers and acoustic products for two-wheelers, passenger vehicles and commercial vehicles.

In the June 2026 quarter, revenue grew 23.6% year on year to Rs 5,563 crore, while net profit rose 2.1% to Rs 316 crore. Revenue rose from Rs 8,376 crore in FY22 to Rs 19,692 crore in FY26, a compound annual growth rate of 23.8%.

Net profit grew from Rs 347 crore in FY22 to Rs 1,284 crore in FY26, which works out to a compound annual growth rate of 38.6%. The company has a return on equity of 17.5%, a debt to equity ratio of 0.40 and a market capitalisation of Rs 61,685 crore. The stock trades at a P/E of 47.8, above the industry P/E of 36.1.

Roadmap: The company is growing in electronics, electric vehicle components and premium products, which carry higher value per vehicle. Acquisitions and joint ventures have widened its technology base.

What to watch: Track electric vehicle component orders, new product launches and international growth.

Why Natco Pharma Features Among These Housewares, Auto Parts and Pharma Stocks

Among the three companies on this list, Natco Pharma is a Hyderabad-based pharmaceutical company focused on complex generics, oncology, and active ingredients, with a significant presence in the United States and other regulated markets.

The company has a return on equity of 15.4%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 15,708 crore. The stock trades at a P/E of 13.7, below the industry P/E of 36.0.

Revenue rose from Rs 2,044 crore in FY22 to Rs 4,376 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 170 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 68.5%.

Roadmap: The company has a track record of developing difficult-to-make generics and has built a strong position in oncology and specialty drugs. New product launches in regulated markets and investments in research support the pipeline.

What to watch: Check the timing of key product launches in the US and the contribution from new drug approvals.

Cello World vs UNO Minda vs Natco Pharma on Key Financials

The table below sets the three housewares, auto parts and pharma stocks side by side on revenue, profit and margin, using reported figures.

UNO Minda posts the highest return on equity in this group at 17.5%. UNO Minda combines the largest FY26 revenue at Rs 19,692 crore with the fastest revenue growth, a 23.8% compound annual rate.

Key Risks to Check Before Investing in Housewares, Auto Parts and Pharma Stocks

Every theme carries risks that deserve a check before any decision. For these housewares, auto parts and pharma stocks, the main points are:

• Consumer spending. Sales follow festivals, incomes and consumer mood.
• Production cycles. Vehicle output can vary with demand.
• Regulatory approvals. Plant inspections and approvals can affect supplies.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter housewares, auto parts and pharma stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Housewares, Auto Parts and Pharma Stocks

Housewares, auto parts and pharma stocks reward investors who follow demand trends, order books and margins together. Cello World, UNO Minda and Natco Pharma each have a clear plan to grow. Based on the 12 November 2026 close, Cello World trades at Rs 369.45, UNO Minda at Rs 1,386 and Natco Pharma at Rs 808.8.

Download the Univest iOS App or Univest Android App to track housewares, auto parts and pharma stocks, set price alerts and get research-backed stock ideas.

What are housewares, auto parts and pharma stocks?

Ans. Housewares, auto parts and pharma stocks are listed companies that make plastic and steel housewares, writing instruments and cleaning tools, make switches, lighting and sensors for vehicles, and make medicines for cancer and other complex conditions. Their earnings depend on household demand, vehicle output and drug demand. This list looks at three of them, Cello World, UNO Minda and Natco Pharma, using reported FY22 to FY26 financials and the 12 November 2026 closing prices.

Which housewares, auto parts and pharma stocks are covered in this list?

Ans. This list covers Cello World, UNO Minda and Natco Pharma. Based on the 12 November 2026 close, Cello World traded at Rs 369.45, UNO Minda at Rs 1,386 and Natco Pharma at Rs 808.8. Their return on equity ranges from 12.3% to 17.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.7% to 23.8%.

Why do housewares, auto parts and pharma stocks have a strong future roadmap in India?

Ans. Housewares, auto parts and pharma stocks have a strong roadmap in India because rising household spending, growing vehicle output and wider access to specialty treatments keep widening the market for these companies. The main drivers are as follows. Housewares. Households buy branded kitchen products. Auto components. Vehicles carry more electronics. Specialty drugs. Patients need advanced treatments. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Cello World performed financially?

Ans. Revenue rose from Rs 1,375 crore in FY22 to Rs 2,379 crore in FY26, a compound annual growth rate of 14.7%. Net profit grew from Rs 220 crore in FY22 to Rs 332 crore in FY26, which works out to a compound annual growth rate of 10.9%. The company has a return on equity of 12.3%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 7,985 crore. The stock trades at a P/E of 24.6, below the industry P/E of 41.4. Looking ahead, the company is growing its glassware and houseware ranges and expanding its reach in modern retail. A trusted household brand helps it enter new product categories.

How has UNO Minda performed financially?

Ans. Revenue rose from Rs 8,376 crore in FY22 to Rs 19,692 crore in FY26, a compound annual growth rate of 23.8%. Net profit grew from Rs 347 crore in FY22 to Rs 1,284 crore in FY26, which works out to a compound annual growth rate of 38.6%. In the June 2026 quarter, revenue grew 23.6% year on year to Rs 5,563 crore, while net profit rose 2.1% to Rs 316 crore. The company has a return on equity of 17.5%, a debt to equity ratio of 0.40 and a market capitalisation of Rs 61,685 crore. The stock trades at a P/E of 47.8, above the industry P/E of 36.1. Looking ahead, the company is growing in electronics, electric vehicle components and premium products, which carry higher value per vehicle. Acquisitions and joint ventures have widened its technology base.

How has Natco Pharma performed financially?

Ans. Revenue rose from Rs 2,044 crore in FY22 to Rs 4,376 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 170 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 68.5%. The company has a return on equity of 15.4%, a debt to equity ratio of 0.08 and a market capitalisation of Rs 15,708 crore. The stock trades at a P/E of 13.7, below the industry P/E of 36.0. Looking ahead, the company has a track record of developing difficult-to-make generics and has built a strong position in oncology and specialty drugs. New product launches in regulated markets and investments in research support the pipeline.

What risks should investors check before buying housewares, auto parts and pharma stocks?

Ans. Investors should check a few risks before buying housewares, auto parts and pharma stocks. Consumer spending. Sales follow festivals, incomes and consumer mood. Production cycles. Vehicle output can vary with demand. Regulatory approvals. Plant inspections and approvals can affect supplies. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of housewares, auto parts and pharma stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 12 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.